This article reviews the changing management and treatment of atrial fibrillation in accordance with recent evidence and updated guidelines.
Highlights evolving AF management per guidelines; leaves open questions on real-world implementation and outcomes.
Atrial fibrillation (AF) is the most common cardiac arrhythmia and can present as either an acute or chronic condition. AF is a global health-care problem with evidence suggesting an increasing prevalence and incidence worldwide ( Chugh et al, 2014 ). It affects 1–2% of the general population around the world and with an increasingly ageing population, estimates suggest prevalence will at least double in the next 50 years ( Camm et al, 2010 ). This article focuses on the changing management and treatment of AF in line with recent evidence and updated guidelines.
No takes yet. Share an insight, caveat, or question.
Berry et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: